These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1086 related articles for article (PubMed ID: 11325641)
1. The value of bone marrow histology in differentiating between early stage Polycythemia vera and secondary (reactive) Polycythemias. Thiele J; Kvasnicka HM; Zankovich R; Diehl V Haematologica; 2001 Apr; 86(4):368-74. PubMed ID: 11325641 [TBL] [Abstract][Full Text] [Related]
2. Polycythemia rubra vera versus secondary polycythemias. A clinicopathological evaluation of distinctive features in 199 patients. Thiele J; Kvasnicka HM; Muehlhausen K; Walter S; Zankovich R; Diehl V Pathol Res Pract; 2001; 197(2):77-84. PubMed ID: 11261821 [TBL] [Abstract][Full Text] [Related]
3. Bone marrow features of diagnostic impact in erythrocytosis. Thiele J; Kvasnicka HM; Diehl V Ann Hematol; 2005 Jun; 84(6):362-7. PubMed ID: 15803315 [TBL] [Abstract][Full Text] [Related]
4. Diagnosis of polycythemia vera based on bone marrow pathology. Thiele JM; Kvasnicka HM Curr Hematol Rep; 2005 May; 4(3):218-23. PubMed ID: 15865875 [TBL] [Abstract][Full Text] [Related]
5. Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the Thrombocythemia Vera Study Group. Michiels JJ; Juvonen E Semin Thromb Hemost; 1997; 23(4):339-47. PubMed ID: 9263350 [TBL] [Abstract][Full Text] [Related]
6. Relevance of bone marrow features in the differential diagnosis between essential thrombocythemia and early stage idiopathic myelofibrosis. Thiele J; Kvasnicka HM; Zankovich R; Diehl V Haematologica; 2000 Nov; 85(11):1126-34. PubMed ID: 11064463 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of serum erythropoietin level in patients with absolute erythrocytosis. Mossuz P; Girodon F; Donnard M; Latger-Cannard V; Dobo I; Boiret N; Lecron JC; Binquet C; Barro C; Hermouet S; Praloran V Haematologica; 2004 Oct; 89(10):1194-8. PubMed ID: 15477203 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic impact of bone marrow histopathology in polycythemia vera (PV). Thiele J; Kvasnicka HM Histol Histopathol; 2005 Jan; 20(1):317-28. PubMed ID: 15578448 [TBL] [Abstract][Full Text] [Related]
10. WHO bone marrow features and European clinical, molecular, and pathological (ECMP) criteria for the diagnosis of myeloproliferative disorders. Michiels JJ; De Raeve H; Hebeda K; Lam KH; Berneman Z; Schroyens W; Schwarz J Leuk Res; 2007 Aug; 31(8):1031-8. PubMed ID: 17367853 [TBL] [Abstract][Full Text] [Related]
11. Studies of the bone marrow in polycythemia vera and the evolution of myelofibrosis and second hematologic malignancies. Ellis JT; Peterson P; Geller SA; Rappaport H Semin Hematol; 1986 Apr; 23(2):144-55. PubMed ID: 3704666 [TBL] [Abstract][Full Text] [Related]
12. The impact of peripheral blood values and bone marrow findings on prognosis for patients with essential thrombocythemia and polycythemia vera. Abdulkarim K; Ridell B; Johansson P; Kutti J; Safai-Kutti S; Andréasson B Eur J Haematol; 2011 Feb; 86(2):148-55. PubMed ID: 21059102 [TBL] [Abstract][Full Text] [Related]
13. Endogenous erythroid colony assay in patients with polycythemia vera and its clinical significance. Bai J; Shao ZH; Liu H; Shi J; He GS; Cao YR; Cui ZZ; Wu YH; Sun J; Tian Z; Jia HR; Qian LS; Yang TY; Yang CL Chin Med J (Engl); 2004 May; 117(5):668-72. PubMed ID: 15161531 [TBL] [Abstract][Full Text] [Related]
14. Bone marrow morphologic features in polycythemia vera with JAK2 exon 12 mutations. Lakey MA; Pardanani A; Hoyer JD; Nguyen PL; Lasho TL; Tefferi A; Hanson CA Am J Clin Pathol; 2010 Jun; 133(6):942-8. PubMed ID: 20472853 [TBL] [Abstract][Full Text] [Related]
15. Usefulness of the assessment of erythroid progenitors growth for differential diagnosis of primary and secondary polycythemias. Hansz J; Kozłowska-Skrzypczak M; Mencel P Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(5):630-7. PubMed ID: 2448202 [TBL] [Abstract][Full Text] [Related]
16. [A clinical and biological study of 33 cases of polycythemia vera]. Corredoira JC; González M; Pérez R; Casariego E; López MJ; García JF; Arias J Rev Clin Esp; 1990 May; 186(8):378-82. PubMed ID: 2236766 [TBL] [Abstract][Full Text] [Related]
17. Is it justified to perform a bone marrow biopsy examination in sustained erythrocytosis? Thiele J; Kvasnicka HM Curr Hematol Malig Rep; 2006 Jun; 1(2):87-92. PubMed ID: 20425337 [TBL] [Abstract][Full Text] [Related]
18. The significance of bone marrow biopsy and JAK2V617F mutation in the differential diagnosis between the "early" prepolycythemic phase of polycythemia vera and essential thrombocythemia. Gianelli U; Iurlo A; Vener C; Moro A; Fermo E; Bianchi P; Graziani D; Radaelli F; Coggi G; Bosari S; Deliliers GL; Zanella A Am J Clin Pathol; 2008 Sep; 130(3):336-42. PubMed ID: 18701405 [TBL] [Abstract][Full Text] [Related]
19. Diagnosis, pathogenesis and treatment of the myeloproliferative disorders essential thrombocythemia, polycythemia vera and essential megakaryocytic granulocytic metaplasia and myelofibrosis. Michiels JJ; Kutti J; Stark P; Bazzan M; Gugliotta L; Marchioli R; Griesshammer M; van Genderen PJ; Brière J; Kiladjian JJ; Barbui T; Finazzi G; Berlin NI; Pearson TC; Green AC; Fruchtmann SM; Silver RT; Hansmann E; Wehmeier A; Lengfelder E; Landolfi R; Kvasnicka HM; Hasselbalch H; Cervantes F; Thiele J Neth J Med; 1999 Feb; 54(2):46-62. PubMed ID: 10079679 [TBL] [Abstract][Full Text] [Related]
20. Serum erythropoietin in the diagnosis of polycythemia vera. A follow-up study. Remacha AF; Montserrat I; Santamaria A; Oliver A; Barceló MJ; Parellada M Haematologica; 1997; 82(4):406-10. PubMed ID: 9299851 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]